Skye Bioscience SKYE
NASDAQ SKYE
$0.28 0.00 (-0.32%)
At close: Aug 21, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Gains from Investment Securities (2016 - 2023)

Skye Bioscience (SKYE) posted quarterly Gains from Investment Securities of -$3.0 for Q1 2023, up 99.99% year-over-year from -$1.5 in Q1 2022, and up 99.07% quarter-over-quarter from -$323.0 in Q4 2022.

Skye Bioscience (SKYE) Gains from Investment Securities (2016 - 2023) Analysis & Trends

Skye Bioscience (SKYE) has reported Gains from Investment Securities for 5 consecutive years, with -$3.0 the latest figure, recorded in Q1 2023.

  • In Q1 2023, Gains from Investment Securities rose 99.99% year-over-year to -$3.0; the TTM figure through Dec 2023 stood at -$3.0 (up 99.99% YoY), while the FY2023 annual figure was -$3.0, up 99.99% from the prior year.
  • Gains from Investment Securities climbed to -$3.0 in Q1 2023 per SKYE's latest filing, from -$323.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at -$3.0 in Q1 2023 and bottomed at -$43655.0 in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Skye Bioscience 10.86 Mn 10.86 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 -3.00
Mar 31, 2023 -3.00
Dec 31, 2022 -323.00
Dec 31, 2022 -323.00
Sep 30, 2022 -6,228.00
Sep 30, 2022 -6,228.00
Jun 30, 2022 -9,523.00
Jun 30, 2022 -9,523.00
Mar 31, 2022 -43,655.00
Mar 31, 2022 -43,655.00
Dec 31, 2018 5.03 Mn
Dec 31, 2018 5.03 Mn
Sep 30, 2018 1.05 Mn
Sep 30, 2018 1.05 Mn
Jun 30, 2018 1.58 Mn
Jun 30, 2018 1.58 Mn
Mar 31, 2018 -1.16 Mn
Mar 31, 2018 -1.16 Mn
Dec 31, 2017 -446,703.00
Dec 31, 2017 -446,703.00